Glioblastoma Multiforme (Thalamus). (Left) T2-weighted axial MRI; (Middle) T1-weighted axial MRI; (Right) T1-weighted with gadolinium axial MRI. Note the mass in the left thalamus that ring enhances ...

Complementary sequences (T1 postcontrast MRI to delineate the enhancing residual and areas of leptomeningeal dissemination and T2/FLAIR to distinguish areas of infiltrative and nonenhancing tumors) ...

In patients with non-radiographic axial spondyloarthritis, MRI sacroiliitis and HLA-B27 positivity, but not elevated C-reactive protein or responses at week 12, predict long-term certolizumab ...

Fenebrutinib significantly reduced the total number of new gadolinium-enhancing T1 brain lesions compared to placebo, the primary endpoint of the trial (p=0.0022).

Fenebrutinib significantly reduced the total number of new gadolinium-enhancing T1 brain lesions compared to placebo, the primary endpoint of the trial (p=0.0022).